FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1046-1050 September 30, 1999 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Humankind has been besieged through-out its evolution by microorganisms that pose a continual challenge to the survival of the species.¹ Although such ancient killers as tuberculosis and malaria persistently take a toll of millions of lives per year, occasionally the emergence or reemergence of a microbe results in an unexpected, catastrophic pandemic with global public health consequences. As we prepare to leave the 20th century, it is worth reflecting on the fact that within the framework of an enormous but constant burden of a variety of infectious diseases, as well as a number of mini-epidemics, this century has witnessed two . . . [Full Text of this Article]

The Origins of HIV

Scope of the Epidemic

The Successes and Limitations of Antiretroviral Therapy

Prevention of HIV Infection

Development of an HIV Vaccine

Conclusions

Source Information

From the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Address reprint requests to Dr. Fauci at the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, or at afauci@niaid.nih.gov.

References

Related Letters:

AIDS in the 21st Century
Benatar S. R., Minkin S. F., Fauci A. S.
Extract | Full Text  
N Engl J Med 2000; 342:515-517, Feb 17, 2000. Correspondence

This article has been cited by other articles:

• Cowburn, C, Hatherill, M, Eley, B, Nuttall, J, Hussey, G, Reynolds, L, Waggie, Z, Vivian, L, Argent, A (2007). Short-term mortality and implementation of antiretroviral treatment for critically ill HIV-infected children in a developing country. Arch. Dis. Child. 92: 234-241 [Abstract] [Full Text]  
• Borrell, C., Rodriguez-Sanz, M., Pasarin, M. I., Brugal, M. T., Garcia-de-Olalla, P., Mari-Dell'Olmo, M., Cayla, J. (2006). AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?. Eur J Public Health 16: 601-608 [Abstract] [Full Text]  
• North, T. W., Van Rompay, K. K. A., Higgins, J., Matthews, T. B., Wadford, D. A., Pedersen, N. C., Schinazi, R. F. (2005). Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1. J. Virol. 79: 7349-7354 [Abstract] [Full Text]  
• Nakata, H., Maeda, K., Miyakawa, T., Shibayama, S., Matsuo, M., Takaoka, Y., Ito, M., Koyanagi, Y., Mitsuya, H. (2005). Potent Anti-R5 Human Immunodeficiency Virus Type 1 Effects of a CCR5 Antagonist, AK602/ONO4128/GW873140, in a Novel Human Peripheral Blood Mononuclear Cell Nonobese Diabetic-SCID, Interleukin-2 Receptor {gamma}-Chain-Knocked-Out AIDS Mouse Model. J. Virol. 79: 2087-2096 [Abstract] [Full Text]  
• Hofman, M. J., Higgins, J., Matthews, T. B., Pedersen, N. C., Tan, C., Schinazi, R. F., North, T. W. (2004). Efavirenz Therapy in Rhesus Macaques Infected with a Chimera of Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother. 48: 3483-3490 [Abstract] [Full Text]  
• Kawamura, T., Bruce, S. E., Abraha, A., Sugaya, M., Hartley, O., Offord, R. E., Arts, E. J., Zimmerman, P. A., Blauvelt, A. (2004). PSC-RANTES Blocks R5 Human Immunodeficiency Virus Infection of Langerhans Cells Isolated from Individuals with a Variety of CCR5 Diplotypes. J. Virol. 78: 7602-7609 [Abstract] [Full Text]  
• Benatar, S. R. (2004). Health Care Reform and the Crisis of HIV and AIDS in South Africa. NEJM 351: 81-92 [Full Text]  
• Ildgruben, A. K., Sjoberg, I. M., Hammarstrom, M.-L. K. C. (2003). Influence of Hormonal Contraceptives on the Immune Cells and Thickness of Human Vaginal Epithelium. Obstet Gynecol 102: 571-582 [Abstract] [Full Text]  
• Otieno, M. W., Banura, C., Katongole-Mbidde, E., Johnson, J. L., Ghannoum, M., Dowlati, A., Renne, R., Arts, E., Whalen, C., Lederman, M. M., Remick, S. C. (2002). Therapeutic Challenges of AIDS-Related Non-Hodgkin's Lymphoma in the United States and East Africa. JNCI J Natl Cancer Inst 94: 718-732 [Abstract] [Full Text]  
• Van Rompay, K. K. A., Matthews, T. B., Higgins, J., Canfield, D. R., Tarara, R. P., Wainberg, M. A., Schinazi, R. F., Pedersen, N. C., North, T. W. (2002). Virulence and Reduced Fitness of Simian Immunodeficiency Virus with the M184V Mutation in Reverse Transcriptase. J. Virol. 76: 6083-6092 [Abstract] [Full Text]  
• Zaneveld, L. J.D., Waller, D. P., Anderson, R. A., Chany II, C., Rencher, W. F., Feathergill, K., Diao, X.-H., Doncel, G. F., Herold, B., Cooper, M. (2002). Efficacy and Safety of a New Vaginal Contraceptive Antimicrobial Formulation Containing High Molecular Weight Poly(Sodium 4-Styrenesulfonate). Biol. Reprod. 66: 886-894 [Abstract] [Full Text]  
• BECK, J. M., ROSEN, M. J., PEAVY, H. H. (2001). Pulmonary Complications of HIV Infection . Report of the Fourth NHLBI Workshop. Am. J. Respir. Crit. Care Med. 164: 2120-2126 [Full Text]  
• Gibbs, R. S. (2001). IMPACT OF INFECTIOUS DISEASES ON WOMEN'S HEALTH: 1776-2026. Obstet Gynecol 97: 1019-1023 [Abstract] [Full Text]  
• Wei, C. C-Y, Gardner, S., Rachlis, A., Pack, L. L., Chan, C. K. N. (2001). Risk Factors for Prophylaxis Failure in Patients Receiving Aerosol Pentamidine for Pneumocystis carinii Pneumonia Prophylaxis. Chest 119: 1427-1433 [Abstract] [Full Text]  
• Fultz, P. N., Vance, P. J., Endres, M. J., Tao, B., Dvorin, J. D., Davis, I. C., Lifson, J. D., Montefiori, D. C., Marsh, M., Malim, M. H., Hoxie, J. A. (2001). In Vivo Attenuation of Simian Immunodeficiency Virus by Disruption of a Tyrosine-Dependent Sorting Signal in the Envelope Glycoprotein Cytoplasmic Tail. J. Virol. 75: 278-291 [Abstract] [Full Text]  
• Kawamura, T., Cohen, S. S., Borris, D. L., Aquilino, E. A., Glushakova, S., Margolis, L. B., Orenstein, J. M., Offord, R. E., Neurath, A. R., Blauvelt, A. (2000). Candidate Microbicides Block HIV-1 Infection of Human Immature Langerhans Cells within Epithelial Tissue Explants. JEM 192: 1491-1500 [Abstract] [Full Text]  
• Slovis, T. L. (2000). New Horizons in Pediatric Radiology. Radiology 216: 317-320 [Full Text]  
• Szabo, R., Short, R. V (2000). How does male circumcision protect against HIV infection?. BMJ 320: 1592-1594 [Full Text]  
• Reich, M. R. (2000). The Global Drug Gap. Science 287: 1979-1981 [Abstract] [Full Text]  
• CUNNINGHAM, E. T JR (2000). Uveitis in HIV positive patients. Br. J. Ophthalmol. 84: 233-236 [Full Text]  
• Benatar, S. R., Minkin, S. F., Fauci, A. S. (2000). AIDS in the 21st Century. NEJM 342: 515-517 [Full Text]  
• Henry, K. (2000). The Case for More Cautious, Patient-Focused Antiretroviral Therapy. ANN INTERN MED 132: 306-311 [Abstract] [Full Text]  
• Maeda, K., Yoshimura, K., Shibayama, S., Habashita, H., Tada, H., Sagawa, K., Miyakawa, T., Aoki, M., Fukushima, D., Mitsuya, H. (2001). Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5. J. Biol. Chem. 276: 35194-35200 [Abstract] [Full Text]  
• Dragic, T., Trkola, A., Thompson, D. A. D., Cormier, E. G., Kajumo, F. A., Maxwell, E., Lin, S. W., Ying, W., Smith, S. O., Sakmar, T. P., Moore, J. P. (2000). A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. USA 97: 5639-5644 [Abstract] [Full Text]